Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Alnylam’s Amvuttra To Take Off From Onpattro’s Runway
Most Onpattro Patients Expected To Switch
Jun 14 2022
•
By
Alaric DeArment
Alnylam's Amvuttra won FDA approval on 13 June for hATTR-PN • Source: Shutterstock
More from New Products
More from Scrip